These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 23219304

  • 1. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure.
    Savarese G, Costanzo P, Cleland JG, Vassallo E, Ruggiero D, Rosano G, Perrone-Filardi P.
    J Am Coll Cardiol; 2013 Jan 15; 61(2):131-42. PubMed ID: 23219304
    [Abstract] [Full Text] [Related]

  • 2. ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
    Ricci F, Di Castelnuovo A, Savarese G, Perrone Filardi P, De Caterina R.
    Int J Cardiol; 2016 Aug 15; 217():128-34. PubMed ID: 27179902
    [Abstract] [Full Text] [Related]

  • 3. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J, Zhang W, Zhang X, Han F, Li X, He X, Li Q, Chen J.
    JAMA Intern Med; 2014 May 15; 174(5):773-85. PubMed ID: 24687000
    [Abstract] [Full Text] [Related]

  • 4. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C, Gan T, Zou L, Sun Y, Zhang Y, Chen W, Li J, Zhang J, Xu Y, Lu H, Xu D.
    BMC Cardiovasc Disord; 2017 Oct 05; 17(1):257. PubMed ID: 28982370
    [Abstract] [Full Text] [Related]

  • 5. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
    Savarese G, Edner M, Dahlström U, Perrone-Filardi P, Hage C, Cosentino F, Lund LH.
    Int J Cardiol; 2015 Nov 15; 199():415-23. PubMed ID: 26247798
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
    Hoang V, Alam M, Addison D, Macedo F, Virani S, Birnbaum Y.
    Cardiovasc Drugs Ther; 2016 Apr 15; 30(2):189-98. PubMed ID: 26861251
    [Abstract] [Full Text] [Related]

  • 7. Incidence of new stroke or new myocardial infarction or death at 39-month follow up in patients with diabetes mellitus, hypertension, or both treated with and without angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Ravipati G, Aronow WS, Ahn C, Alappat RM, McClung JA, Weiss MB.
    Am J Ther; 2009 Apr 15; 16(1):2-4. PubMed ID: 19114876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in hypertensive patients with myocardial infarction or heart failure: a systematic review and meta-analysis.
    Ohtsubo T, Shibata R, Kai H, Okamoto R, Kumagai E, Kawano H, Fujiwara A, Kitazono T, Murohara T, Arima H.
    Hypertens Res; 2019 May 15; 42(5):641-649. PubMed ID: 30948834
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M, Tocci G, Sciarretta S, Verdecchia P, Trimarco B, Mancia G.
    J Hypertens; 2009 May 15; 27(5):941-6. PubMed ID: 19381108
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials.
    McAlister FA, Renin Angiotension System Modulator Meta-Analysis Investigators.
    Eur Heart J; 2012 Feb 15; 33(4):505-14. PubMed ID: 22041554
    [Abstract] [Full Text] [Related]

  • 13. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M, Furumoto T, Kinugawa S, Hamaguchi S, Goto K, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H, JCARE-CARD Investigators.
    Hypertens Res; 2010 Mar 15; 33(3):197-202. PubMed ID: 19960016
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Should all patients at high cardiovascular risk receive renin-angiotensin system blockers?
    Volpe M.
    QJM; 2012 Jan 15; 105(1):11-27. PubMed ID: 22011630
    [Abstract] [Full Text] [Related]

  • 20. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis.
    Wang K, Hu J, Luo T, Wang Y, Yang S, Qing H, Cheng Q, Li Q.
    Kidney Blood Press Res; 2018 Jan 15; 43(3):768-779. PubMed ID: 29794446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.